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Brg1-mediated Nrf2/HO-1 pathway activation alleviates
hepatic ischemia–reperfusion injury
Mian Ge1,5, Weifeng Yao1,5, Dongdong Yuan1,5, Shaoli Zhou1, Xi Chen1, Yihan Zhang1, Haobo Li2,3,4, Zhengyuan Xia*,2,3,4 and
Ziqing Hei*,1
Cytoprotective gene heme oxygenase 1 (HO-1) could be induced by nuclear factor E2-related factor 2 (Nrf2) nuclear translocation.
The purpose of this study was to determine the role of Brahma-related gene 1 (Brg1), a catalytic subunit of SWI2/SNF2-like
chromatin remodeling complexes, in Nrf2/HO-1 pathway activation during hepatic ischemia–reperfusion (HIR). Our results showed
that hepatic Brg1 was inhibited during early HIR while Brg1 overexpression reduced oxidative injury in CMV-Brg1 mice subjected to
HIR. Moreover, promoter-driven luciferase assay showed that overexpression of Brg1 by adenovirus transfection in AML12 cells
selectively enhanced HO-1 gene expression after hypoxia/reoxygenation (H/R) treatment but did not affect the other Nrf2 target
gene NQO1. Furthermore, inhibition of HO-1 by the selective HO-1 inhibitor zinc protoporphyria could partly reverse the hepatic
protective effects of Brg1 overexpression while HO-1-Adv attenuated AML12 cells H/R damage. Further, chromatin
immunoprecipitation analysis revealed that Brg1 overexpression, which could significantly increase the recruitment of Brg1
protein to HO-1 but not NQO1 promoter, was recruited by Nrf2 to the HO-1 regulatory regions in AML12 hepatocytes subjected to
H/R. In conclusion, our results demonstrated that restoration of Brg1 during reperfusion could enhance Nrf2-mediated inducible
expression of HO-1 during HIR to effectively increase antioxidant ability to combat against hepatocytes damage.
Cell Death and Disease (2017) 8, e2841; doi:10.1038/cddis.2017.236; published online 1 June 2017
Hepatic ischemia–reperfusion (HIR) injury occurs inevitably
during liver transplantation, trauma, hemorrhagic shock and
other systemic low-flow diseases such as sepsis, respiratory
failure and congestive heart failure.1–4 HIR features in
excessive production of reactive oxygen species (ROS) from
various sources, leading to disturbance of the oxidation–
antioxidation balance.5,6 Excessive free heme, which is
released from heme proteins under oxidative conditions,
may be a major threat because it can catalyze the over-
production of ROS.7
Antioxidant enzyme heme oxygenase (HO-1), a rate-limiting
enzyme in heme degradation,8 is highly inducible by a variety
of discriminating stimuli inducing hepatic oxidative stress.9,10
HO-1 transcription is modulated by an intertwined circuit in
which nuclear factor E2-related factor 2 (Nrf2) plays an
essential role.11 Nrf2 deficiency has been shown to exacer-
bate HIR injury and hepatocyte-specific Nrf2 overactivation
provided protection against warm HIR.12 In resting cells, Nrf2
is retained in the cytoplasm as an inactive complex with Kelch-
like ECH-associated protein 1 (Keap1).13 When cells are
exposed to electrophiles or other reactive species, such as
ROS, Nrf2 is released from the complex and translocate from
cytoplasm into the nucleus. Once migrated to the nucleus,
Nrf2 forms heterodimers with small Maf proteins and subse-
quently binds to the cis-acting antioxidant response element
(ARE) within the gene promoters including HO-1 and
NQO1.14,15 The binding leads to transcriptional activation of
a battery of genes that encode an array of phase II detoxifying
or antioxidant enzymes, such as HO-1 and NQO1, as well as
other cytoprotective proteins.16–18
Brahma-related gene 1 (Brg1) is the core ATPase in the
SWI/SNF complex, which plays a central role in the activation
and transcription of genes in mammalian cells.19 Brg1 has
been reported to participate in the transactivation of proin-
flammatory mediators in macrophages treated with
lipopolysaccharide.20 Interestingly, some recent studies indi-
cated that Brg1 upregulation could also exert an antioxidative
effect.21 Moreover, study showed that small interfering RNA
knockdown of Brg1 in colon cancer cell SW480 selectively
decreased inducible expression of HO-1 gene after diethyl-
maleate treatment in vitro.22 However, whether overexpres-
sion of Brg1 could enhance Nrf2-mediated HO-1 gene
transcription in hepatocyte subjected to ischemia/hypoxia
and subsequent reperfusion/reoxygenation in vivo or in vitro in
the epigenetic machinery remained unknown, if so, over-
expression of Brg1 maybe a potential therapy in liver diseases
involving ischemia–reperfusion.
Therefore, we sought to determine whether or not over-
expression of Brg1 may have antioxidative effect against the
hepatic damage during HIR, and if so, whether it functions via
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enhancing Nrf2-mediated HO-1 gene transcription in hepato-
cyte through epigenetic modification by Brg1.
Results
Ischemia–reperfusion induced liver pathological and
oxidative stress. Mice were subjected to 70% hepatic
ischemia for 60 min, followed by 3, 6, 12 or 24 h of reperfusion.
As shown in Figure 1, compared to mice in the sham group,
mice receiving HIR displayed collapse of hepatic architecture
that was associated with severe congestion, intracellular edema
and necrosis, resulting in significantly elevated total histopatho-
logical Suzuki’ score (Po0.05, Figures 1a and b), which
maximized at 6 h after the onset of reperfusion. These
pathological changes were corresponded to liver functional
changes, evidenced by increases of serum aspartate amimo-
transferase (AST) and alanine aspartate amimotransferase
(ALT) levels after reperfusion and peaked at 6 h after reperfu-
sion (Po0.05, Figures 1c and d). These patterns of pathological
injury were mirrored with significant elevation of oxidative stress
in the liver, manifested by enhanced 8-isoprostane formation
and increased ROS production (Figures 1e and f). The above
results indicated that HIR induced serious liver injury during
reperfusion as early as 6 h after reperfusion, in which oxidative
stress may play a critical role.
Hepatic Brg1 was decreased during early liver ischemia–
reperfusion. To explore the role of Brg1 in HIR, the changes
of Brg1 were determined during the progression of HIR injury.
Compared with the sham group, both mRNA and protein
expressions of Brg1 were decreased at 3 h after HIR, which
gradually recovered from 12 to 24 h after HIR (Figures 2a
and e). Furthermore, the changes of mRNA and protein
expression of Nrf2, the possible target of Brg1, and its
downstream targets, HO-1 and NQO1 were detected.
Interestingly, Nrf2 (Figures 2b and f) and antioxidant enzyme
HO-1 and NQO1 (Figures 2c, d, g and h) were gradually
elevated from 3 h after HIR and peaked at 24 h after HIR.
Brg1 overexpression reduced oxidative injury during
HIR. Brg1 was reduced after HIR that was associated with
enhanced hepatic oxidative stress and liver injury, indicating a
critical role of Brg1 in HIR. Thus, transgenic mice with Brg1
overexpression, cytomegalovirus (CMV)-Brg1 mice, were
employed and subjected to HIR in vivo to examine whether
or not liver with overexpression of Brg1 can attenuate HIR. We
performed 60min of ischemia and 6 h of reperfusion or sham
operation in both wild-type and CMV-Brg1 mice. As shown in
Figure 3, high expression of Brg1 protein and mRNA
(Figure 3a) were confirmed in CMV-Brg1 mice. After 60 min
of ischemia and 6 h of reperfusion, compared to wild-type (WT)
mice, HIR injury was significantly attenuated in CMV-Brg1
mice evidenced by reduced Suzuki’ score, hepatic congestion,
intracellular edema and necrosis (Figures 3b and c), accom-
panied with improved liver function manifested by lower serum
AST and ALT levels (Figures 3d and e). Similar trend was
observed in hepatic oxidative stress, compared with WT mice,
Brg1 overexpression dramatically decreased post-HIR hepatic
oxidative stress, evidenced by decrease of hepatic 8-
isoprostane formation (Figure 3f) and ROS production
(Figure 3g) (Po0.01). Interestingly, the expression HO-1
(Figures 3h–i) but not NQO1 (Figure 3j) in the liver was also
elevated significantly in CMV-Brg1 mice subjected to HIR
(Po0.01 versusWT HIR group). These results suggested that
overexpression of Brg1 could attenuate liver damage induced
by HIR by effectively reducing liver oxidative stress.
Brg1 reduced HIR-induced hepatic oxidative stress by
enhancing Nrf2 and HO-1. Study showed that in response
to oxidative stress, Brg1 interacts with Nrf2 to mediate HO-1
Figure 1 HI/R-induced liver damage. Animals were subjected to 70% liver warm ischemia for 60 min (min) and live tissues were collected at indicated time points. (a) Liver
pathology was detected by H&E staining of liver paraffin sections. Representative H&E staining images are shown. (b) Suzike’s injury score was used as criteria to evaluate the
injury degree of liver injury. (c and d) Liver function was evaluated by detection of serum ASTand ALT concentration. (e) ELISA analysis showed 8-isoprostane level was elevated
in response to HIR injury. (f) ROS production in liver after HIR was measured by fluorescence intensity of DCF using a fluorescence spectrophotometer. Each bar represents the
mean± S.E.M. (n= 6 per group). *Po0.05, **Po0.01, one-way ANOVA with Tukey test
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induction.22 To determine the role of Nrf2 and HO-1 in Brg1-
mediated attenuation of HIR injury, we established an in vitro
cell model by subjecting AML12 hepatocytes to hypoxia/
reoxygenation (H/R), which closely mimicked the stimuli and
the effects of in vivo HIR and could effectively enhance Brg1
expression with adenovirus infection and reduce Brg1 by
gene silence. As shown in Supplementary Figure S1, AML12
cells were subjected to 4, 8 or 12 h of hypoxia, followed by 2,
4, 6 or 8 h of reoxygenation. Significant cell injury (reduced
cell viability and increased lactate dehydrogenase (LDH))
was observed when cells subjected to 12 h of hypoxia and 4 h
of reperfusion (Supplementary Figures S1A–B). Also, we
found both Brg1 and HO-1 protein expression were
decreased in the early stage (0–6 h) of H/R and then
gradually elevated from 8 h after cells reoxygenation
(Figures 4a–c). We postulated that the reduction of Brg1 at
early state of H/R played an important role in regulating HO-1
expression, and that restoring early HO-1 expression via
Brg1 overexpression may attenuate hepatocytes H/R
damage. Subsequently, we chose the model of hypoxia
12 h/reoxygenation 4 h, a time point at which both Brg1 and
HO-1 protein expression reached their minimum level to
explore the underlying mechanism. Thus, 12 h of hypoxia and
4 h of reoxygenation was chosen for our ensuring
experiments.
As shown in Figure 4, H/R significantly increased hepato-
cytes oxidative stress evidenced as increased ROS produc-
tion (Figures 4d and e) and elevated 8-isoprostane formation
(Figure 4f), which was associated with decreased Brg1
expression (Figure 4g), enhanced protein expression of Nrf2
(Figure 4h) but reduced mRNA and protein expression and
promoter luciferase activities of HO-1 and NQO1 (Figures
4i–k). Brg1 overexpression attenuated post-H/R oxidative
stress accompanied by enhanced protein expression of Nrf2
as well as increased HO-1 induction and promoter luciferase
activity. All these changes were canceled by Brg1 gene
knockdown. Interestingly, Brg1 overexpression had no impact
on H/R-induced reduction mRNA and protein expression and
promotor luciferase activity of NQO1.
HO-1 inhibition partly reversed the protective effects of
Brg1 in HIR. To confirm the role of HO-1 in Brg1-mediated
attenuation of HIR injury, HO-1 was inhibited with zinc
protoporphyria (ZnPP) or overexpressed with adenovirus
Adv-HO-1 in CMV-Brg1 mice or AML12 hepatocytes in the
presence or absence of HIR or H/R. We found that HO-1
inhibition with ZnPP (Figures 5a and c) deteriorated the liver
function as assessed by AST and ALT (Figure 5b) and
pathological change (Figure 5a) in CMV-Brg1 mice subjected
to HIR. Furthermore, HO-1 overexpression with Adv-HO-1
attenuated Brg1 gene knockdown-induced exacerbation
post-H/R oxidative stress in AML12 hepatocytes manifested
as increase of DCFH-DA fluorescence (Figure 5d) and
elevation of 8-isoprostane level (Figure 5e). These results
indicated that HO-1 inhibition could partly reverse the
protective effects of Brg1 overexpression during HIR or
hepatocytes H/R injury.
Brg1 facilitated Nrf2 to promote HO-1 induction during
H/R. We have showed that Brg1-mediated attenuation of
oxidative stress in hepatocytes subjected to H/R by enhan-
cing Nrf2 and HO-1, in order to determine how HO-1
promoter was regulated by Brg1 and Nrf2 interaction,
luciferase assay was performed. HO-1 luciferase activity
was increased in AML12 cells after transfected with Brg1-Adv
plasmid. tBHQ (20 μM) was used as Nrf2 nuclear
Figure 2 Expressions of Brg1, Nrf2 and Nrf2 downstream genes in the liver after hepatic I/R. (a, b, c and d) Western blot analysis showed that Brg1, nuclear Nrf2, HO-1 and
NQO1 protein expressions were elevated in response to HIR in the liver at indicated time points. Representative images from one of three independent experiments were shown.
Quantitative analyses of the results were also performed. (e, f, g and h) Transcript levels of Brg1, Nrf2, HO-1 and NQO1 in the liver in sham and HIR group were measured by RT-
PCR. Each bar represents the mean± S.E.M. (n= 6 per group). *Po0.05, **Po0.01, one-way ANOVA with Tukey test
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translocation positive control. H/R decreased HO-1 luciferase
activity, which was restored by Brg1-Adv plasmid transfec-
tion. However, the Brg-1-Adv-induced HO-1 luciferase activity
elevation was canceled by transfection with Neh4 and/or
Neh5 Nrf2 mutants (△Neh4 and/or △Neh5) transfection in
AML12 cells subjected to H/R (Figure 6a), suggesting that
Brg1 may directly interact with Neh4/Neh5 Nrf2 domains to
facilitate HO-1 gene expression. Next, to exposure whether
Brg1 directly interacted with HO-1 promoter in this process,
chromatin immunoprecipitation (ChIP) assay was applied in
our current study. AML12 hepatocytes were pretreated with or
without Brg1-siRNA or Brg1-Adv and then subjected to
hypoxia for 12 h and reoxygenation for 4 h before sample
collection. ChIP analysis was performed with the anti-Brg1
Figure 3 Overexpression of Brg1 attenuated HIR injury via enhancing antioxidant enzyme. Animals were subjected to 70% liver warm ischemia for 60 min and live tissues
were collected at 6 h after reperfusion. (a) Western blot analysis showed that Brg1 expression was increased in Brg1 overexpression (CMV-Brg1) mice compared to WT mice
both in the sham and HIR groups. (b) Suzike’s injury score showed lower scores in CMV-Brg1 mice than in WT mice after HIR injury. (c) Representative H&E staining images of
liver collected from WTand CMV-Brg1 mice in the sham and HIR groups are shown. (d and e) Serum ASTand ALT concentration showed an improved liver function in CMV-Brg1
mice after HIR injury. (f) ELISA analysis showed elevation of 8-isoprostane level was attenuated in CMV-Brg1 mice in response to HIR injury relative to that in the control. (g) ROS
production measured by fluorescence intensity of DCF was reduced in CMV-Brg1 mice after HIR injury. (h) Immumohistochemical staining showed that liver HO-1 protein
expression was elevated in response to HIR in CMV-Brg1 mice. (i) Quantitative analyses of the results from h were also performed. (j) Western blot analysis showed that liver
NQO1 protein expression did not significantly change in CMV-Brg1 mice compared to WT mice. Each bar represents the mean± S.E.M. (n= 6 per group). *Po0.05, **Po0.01,
one-way ANOVA with Tukey test. Imaginary line indicated the edge of apoptosis liver tissue
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antibody and primers of HO-1 were used in this experiment.
ChIP analysis revealed that the recruitment of Brg1 protein
found in the HO-1 promoter was markedly reduced in
response to Brg1-siRNA, and Brg1 overexpression could
significantly increase the recruitment between Brg1 protein
and HO-1 promoter (Po0.01 versus control) (Figure 6b).
To further explore the interplay between Nrf2 and Brg1 in
H/R-induced transactivation of HO-1 gene, we knocked down
Nrf2 with siRNA in AML12 hepatocytes. Brg1 was immuno-
precipitated with antibody conjugated to agarose beads,
followed by immunoblotting with anti-Nrf2 antibodies. As
shown in Figure 6c, we found that there existed a strong
association/interaction between Brg1 and nuclear Nrf2, but
this interaction was much weaker upon H/R. Brg1-Adv treat-
ment could significantly promote Brg1/Nrf2 co-localization.
However, siRNA targeting Nrf2 could reduce the
co-localization of Brg1/Nrf2 (Figure 6d). Taken together, these
results support a model wherein a Brg1/Nrf2 complex form on
the HO-1 promoter in response to H/R to activate transcription
in hepatocytes cells as described in Figure 6e.
Discussion
Oxidative stress is triggered by ROS released from HIR or
H/R. Nrf2 activation and the downstream antioxidant enzyme
upregulation during the early stage of HIR could promote the
Figure 4 The role of Brg1 in AML12 cells subjected to H/R injury. (a) Western blot analysis showed the cellular Brg1 and HO-1 protein expression in AML12 hepatocytes
subjected to hypoxia for 12 h and reoxygenation for 0 (H12R0), 2 (H12R2), 4 (H12R4), 6 (H12R6), 8 (H12R8), 12 (H12R12), 16 (H12R16) and 24 h (H12R24) before sample
collection in comparison with the cells cultured for the same time as control (namely, C12, C14, C16, C20, C24, C28 and C36, representing 12–36 h of culture). The proteins from
the H/R groups and from the control groups were loaded in the same gel when performing western blotting assay and displayed in parallel to facilitate comparison. Representative
images from one of three independent experiments were shown. (b and c) Quantitative measurement of band intensity in a by densitometry analysis. (d) Fluorescence
immunostaining of DCF in cells with Brg1 overexpression using Brg1-Adv transfection, and elevated in cells with Brg1 knockdown using Brg1-siRNA transfection during H/R
(H12R4) injury. Representative images from one of three independent experiments were shown. (e) Bar graph showing the change in DCF fluorescent intensity. (f) ELISA assay
showed that 8-isoprostane level was decreased after Brg1-Adv treatment and increased by Brg1-siRNA transfection during H/R (H12R4) injury. (g and h) Western blot analysis
showed the change of Brg1 and Nrf2 protein expression in AML12 cells, respectively, under condition of Brg1 overexpression or knockdown. Representative images were shown
and quantitative measurements were performed. (i and j) Western blot and RT-PCR analysis showed the protein and mRNA level of HO-1 and NQO1 in response to Brg1
overexpression or knockdown during cell H/R (H12R4) injury. (k) HO-1 promoter-driven luciferase activity assay was performed and tBHQ (20 μM) was used as Nrf2 nuclear
translocation positive control. Data are mean± S.E.M. of three independent experiments each performed in triplicate. *Po0.05, **Po0.01, one-way ANOVA with Tukey test
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functional recovery of the impaired liver. The key to this
process is the transactivation of antioxidant enzyme mediated
by Nrf2 in response to HIR. Here we report that epigenetic
factors Brg1 contributes to Nrf2-mediated HO-1 gene trans-
activation, which is critically involved in the pathogenesis of
HIR injury.
Ischemia/reperfusion injury is characterized as a pathophy-
siologic process whereby hypoxic organ damage is accen-
tuated following return of blood flow and oxygen delivery.23
One of the principal causes of HIR injury is the inherent
oxidative damage that occurs during reperfusion inflicted by
the generation of ROS.24 The extent of early ROS formation is
critical to themagnitude of the final tissue injury and enhancing
hepatic antioxidant capacity has been proven to be effective in
reducing HIR injury.25 Promoting the transcription efficiency of
antioxidant enzyme may be potentially a novel promising
therapeutic option for HIR injury.26 Nevertheless, the approach
to enhancing transcription efficiency is still lacking.
Gene transcription is tightly regulated at different levels to
ensure that the transcriptome of the cell is appropriate for
developmental stage and cell type.27 The chromatin state in
which a gene is embedded determines its expression level to a
large extent.28 Activation of transcription is typically accom-
plished by the recruitment of chromatin-associated multi-
subunit protein complexes including SWI/SNF.29 As the core
ATPase of SWI/SNF, Brg1 is essential in vivo, suggesting that
Brg1 containing SWI/SNF nucleosomal remodeling com-
plexes are critical in mammalian organisms.19 Brg1 regulates
chromatin structure in response to stress, and we found that
Brg1was gradually increased in the liver during the early stage
(6–24 h) of reperfusion after a transient decrease at the onset
of reperfusion (before 3 h). By using the CMV-Brg1 transgenic
mice in which Brg1 was overexpressed, we found that Brg1
overexpression could effectively reduce the oxidative stress
occurred during the reperfusion period. This is a novel finding,
sincemost studies havemerely and controversially shown that
Brg1-dependent pathway connects the epigenetic regulation
of proinflammatory genes rather than antioxidant genes to the
pathogenesis of inflammation disease.30 However, the
mechanism of Brg1 antioxidant activity in HIR is unclear.
Nrf2 is a stress-sensing genetic transcription factor, which
appears to be a master regulator of cellular responses to
oxidative damage and other stressful conditions. The Nrf2
antioxidant response pathway is ‘the primary cellular defense
against the cytotoxic effects of oxidative stress’.31 Strategies
that can effectively activate transcription factor Nrf2 and
promote the downstream antioxidant enzyme genes transcrip-
tion may lead to better outcome during HIR.32 It is well known
that ROS can activate signal transducing molecules through
the effects on oxidation-prone cysteine-rich domains, thereby
Figure 5 Inhibition of HO-1 reversed the protective effects of Brg1 overexpression. CMV-Brg1 transgenic mice subjected to HIR with or without HO-1 inhibitor ZnPP. Animals
were killed at 6 h after reperfusion onset. (a) Liver pathology was detected by H&E staining and HO-1 expression was measured by immunohistochemical staining.
Representative images from one of three independent experiments were shown. (b) The effects of HO-1 inhibition on Brg1-CMV mice post-HIR liver function were examined by
AST and ALT. (c) Quantitative measurement of HO-1 immunohistochemical staining density in a by densitometry analysis. (d and e) Furthermore, AML12 cells injury was
attenuated by overexpression of HO-1 in hepatocytes subjected to H/R (H12R4). Cell DCF fluorescence was detected and relative DCF fluorescence intensity was assayed.
Representative images from one of three independent experiments were shown. (f) Cell 8-isoprostane was detected by ELISA assay to show the cellular oxidative stress level.
Data are mean± S.E.M. of three independent experiments each performed in triplicate. *Po0.05, **Po0.01, one-way ANOVA with Tukey test. Silencer negative control
scrambled (Scr) siRNA was used as a control
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activating gene transcription, and we found that Nrf2 was
activated during liver oxidative injury in HIR. However, the
production of Nrf2 downstream antioxidant HO-1 and NQO1
was insufficient to reduce oxidative stress and unable to curb
hepatic damage amplification. In addition, we found that
chromatin remodeling factor Brg1was suppressed both in vitro
and in vivo during early HIR and that overexpression of Brg1
could promote Nrf2 transcription and dramatically induce the
downstream enzyme HO-1 gene expression, which was
consistent with other observation which showed that Brg1
could modulate the expression of alpha interferon-inducible
gene through interactions with specific transcription factor
STAT2.33 Despite that inflammation mediated by upregulation
of Brg1 induced endothelial injury in the pathogenesis of
atherosclerosis,27 the Nrf2/HO-1 pathway activated by Brg1
upregulation in the present study was found to protect the liver
against HIR injury.
Under basal conditions, the physiological low-level expres-
sion of HO-1 functions to maintain redox hemeostasis,
cooperating with other antioxidant enzymes. However, no
apparent histological abnormalities were observed in
hepatocyte-specific conditional HO-1 gene knockout mice
under normal condition.34 In contrast, the inducible expression
of HO-1 was thought to be more important than its basal
expression for hepatic HO-1 functions. Induction of HO-1
expression involves two fundamental regulatory pathways
either via a heme-dependent or a heme-independent
mechanism.35 Despite the differences in the two pathways,
the effects of the diverse factors on hepatic HO-1 gene
expression appear to be controlled mainly at the transcrip-
tional level. HO-1 genes have two important distal enhancer
regions, E1 and E2.36 The dominant element in the two
regions is the stress-responsive element, which mediates
transcriptional activation in response to almost all HO-1
inducers tested (Figure 4e). In our study, although inducible
HO-1 has an about 80% increase during the first 3–6 h of HIR,
the oxidative stress/antioxidant balance was still inclined to
oxidative stress and liver damage occurred, which were
associated with decreased Brg1 expression, suggesting that
the decrease of Brg1 may have played a critical role in limiting
Nrf2/HO-1 expression to a higher level to combat against
hepatic oxidative stress and HIR. And this hypothesis was
tested using the CMV-Brg1 mice in which hepatic Brg1 was
overexpressed andNrf2/HO-1 pathway was activated and HIR
injury was reduced. These results indicated that, in order to
combat HIR, a level of HO-1 higher than that in the early phase
of HIR (3–6 h) is needed,which is regulated by Brg1. However,
as the regulation of HO-1 gene expression in the intact liver
was complex and there were different cell types in liver which
may affect the expression of HO-1 in different manners, we
then conducted in vitro experiments and investigated the role
of Brg1 on Nrf2/HO-1 in AML12 hepatocytes to further explore
Figure 6 HO-1 promoter was regulated by Brg1/Nrf2 upon hepatocytes H/R. (a) AML12 cells were transfected with PGL3-HO-1-Luc, Brg1-Adv expression plasmids, Neh4
and/or Neh5 Nrf2 deletion mutants (△Neh4/△Neh5) without or with hypoxia for 12 h and reoxygenation for 4 h. Transfections and HO-1 promoter-driven luciferase assays were
performed and tBHQ (20 μM) was used as Nrf2 nuclear translocation positive control. (b) AML12 hepatocytes were then pretreated without or with Brg1-siRNA, or Brg1-Adv and
then subjected to hypoxia for 12 h and reoxygenation for 4 h before sample collection. ChIP analyses were performed with antibodies against Brg1 and primers for the HO-1
promoter regions. (c and d) Furthermore, hepatocytes were pretreated without or with Nrf2 siRNA and Brg-Adv, then subjected to hypoxia for 12 h and reoxygenation for 4 h, Co-
IP analysis were also performed with antibody against Nrf2. IgG was used as a negative control. Quantitative measurement of Brg1 band intensity was performed by densitometry
analysis. (e) Diagram of HO-1 promoter activated by Brg1/Nrf2 upon H/R. Both human and mouse HO-1 genes have two important distal enhancer regions, E1 and E2, located
about 4 and 10 kbp upstream of the transcription start site. The dominant element in the E1 and E2 regions is the ARE, which mediates transcriptional activation in response to
almost all HO-1 inducers tested. ARE represent binding sites of several transcription factors such as Nrf2. Under HIR condition, nuclear Brg1 interacts with Nrf2 via transactivation
domain, Nrf2 ECH homology (Neh)4 and Neh5, which promotes Nrf2 binding to the ARE within the gene promoter of HO-1. Data are mean± S.E.M. of three independent
experiments each performed in triplicate. *Po0.05, **Po0.01, one-way ANOVA with Tukey test
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the mechanism of Brg1 acts on Nrf2/HO-1 pathway. Interest-
ingly, we found that in AML12 hepatocytes, Brg1 was reduced
during the early phase of reoxygenation (2–6 h), which is in
parallel with the reduction of HO-1 during hypoxia and
reoxygenation, indicating that our in vitro model of hypoxia
reoxygenation may mimic the very early phase (earlier than
3 h) of HIR in mice, a stage that both Brg1 and HO-1 were
reduced in response to HIR.
In addition, we found that Brg1 was selectively recruited to
HO-1 but not NQO1 gene during HIR injury, leading to a
different induction of these two genes through interaction with
Nrf2, and these phenomena were also observed in SW480,
SW13 and 293 T cells in the study of Zhang et al,22 which
showed that knockdown of Brg1 in SW480 cells selectively
decreased the inducible expression of HO-1 gene after
diethylmaleate treatment. We also found that Brg1 activated
HO-1 gene in hepatocytes in oxidative stress state instead of
normal state in which Nrf2 was inactivated indicating that
activation of Brg1 overexpression and Nrf2 activation could
jointly promote HO-1 gene expression in ischemia–reperfu-
sion condition. These were also observed in our previous
study, which showed that adiponectin ameliorated
hyperglycemia-induced cardiac hypertrophy and dysfunction
by concomitantly activating Nrf2 and Brg1.37 Furthermore, we
found that Nrf2 could recruit Brg1 to HO-1 promoter in HIR.
The mechanism of Brg1-mediated Nrf2/HO-1 transcription
has yet to be elucidated. One mechanism could be that Nrf2
independently bind to nucleosomal DNA or DNA between
nucleosomes, and the subsequent binding of Brg1 leads to
instability of neighboring nucleosome and thus sequester
more Nrf2. This is a process of cascade reaction called
reconstruction.38 Another possible mechanism may involve
nucleosome sliding.39 To be specific, Brg1 independently
binds to nucleosome without altering its structure, but unchain
it from DNA to induce nucleosome sliding, which enables the
binding of Nrf2, hereby stabilizing the regions without
nucleosome.40 In Nrf2, there are six domains namely Neh1
(Nrf2 ECH homology 1) to Neh6 that have been identified and
Neh4/Neh5 have been considered as transcription-related
domains.41 In the current study, we found under HIR condition,
nuclear Brg1 interacts with Nrf2 via transactivation domain,
Nrf2 ECH homology (Neh)4 and Neh5, which promotes Nrf2
binding to the ARE within the gene promoter of HO-1. On the
other hand, enhancing Brg1 activity could directly enhance the
binding of Brg1 to HO-1 promoter, subsequently leading to
HO-1 gene transcription (Figure 6e).
Of note, Brg1-mediated dynamic chromatin remodeling
processes are required for the initial step in gene expression,
which is regulated by epigenetic processes including DNA
methylation,42 histone modifications43 and the action of small
noncoding RNAs.44 On the basis of our current results, the
above epigenetic modification changes will be involved in our
further study. Moreover, we only mentioned that Brg1
upregulation protected hepatocytes from H/R damage, and
more attention will be paid in the specific hepatocyte damage
feature, including proliferation reduction, apoptosis or autop-
hagy. In addition, as Brg1 also takes part in the syntheses of
proinflammatory mediators,45 whether overexpression of Brg1
will present proinflammation effect in the late phase of
reperfusion following HIR also needs to be investigated in
the future.
In summary, this study demonstrates that Brg1-mediated
chromatin-remodeling activity is essential for Nrf2 transcrip-
tion and the downstream antioxidant enzyme HO-1 gene
induction during hepatic oxidative stress (Figure 7).
Materials and Methods
Antibodies and reagents. Antibodies recognizing Brg1 and Nrf2 were
purchased from Abcam Company (Cambridge, MA, USA). Antibodies rose against
HO-1 and NQO1 were from Santa Cruz Biotechnology (Dallas, TX, USA), while
antibodies against Lamin B2 and β-actin were from Cell Signaling Technology
(Danvers, MA, USA). HO-1 inhibitor ZnPP, Brg1 (NM_001174078.1) siRNA, Nrf2
(NM_010902.3) siRNA and control siRNA were obtained from Sigma-Aldrich
(St. Louis, MO, USA). Recombinant adenoviruses containing Brg1 (Brg1-Adv,
1 × 1010 pfu/ml) or HO-1(NM_010442, HO-1-Adv, 1 × 1010 pfu/ml) were designed
and prepared from GeneCopoeia company.
Transgenic mice. Brg1 transgenic mice were obtained from Cyagen
Biosciences Inc. (Guangzhou, China). To obtain the CMV-Brg1 mice, first, the
pRP.ExSi-CMV-Brg1 vector was constructed. Brg1 gene was then overexpressed by
using CMV promoter. Next, the pRP.ExSi-CMV-Brg1 vector was linearized and
purified to get the plasmid, which could be used for microinjection. The pronuclei of
fertilized eggs from hyperovulated C57BJ/6N were microinjected with this Brg1 DNA
construct. The fertilized eggs with better state were chose to transplant into
pseudopregnancy mother mouse from the institute of cancer research. Mice were
bred and screened by Southern blot analysis of their tail DNA. Among six
established lines (pRP.ExSi-CMV-Brg1-22, pRP.ExSi-CMV-Brg1-24, pRP.ExSi-CMV-
Brg1-27, pRP.ExSi-CMV-Brg1-41, pRP.ExSi-CMV-Brg1-45 and pRP.ExSi-CMV-Brg1-
51) of transgenic mice, two lines (ExSi-CMV-Brg1-24 and pRP.ExSi-CMV-Brg1-45)
with substantial Brg1 protein expression were used for further experiments. Six
different control mice and six different CMV-Brg1 mice were used in each related
group for experiments. Genotype of Brg1-CMV mice were initially identificated by
reverse transcription-PCR analysis and only phenotypes that were commonly
observed were used in our current study. Brg1 transgene PCR primer forward:
5′-GCACCAAAATCAACGGGAC-3′, reverse: 5′-CTAGGACCCAGCATTG CAC-3′;
Internal control PCR primer forward: 5′-ACTCCAAGGCCACTTATCA CC-3′,
reverse: 5′-ATTGTTACCAACTGGGACGACA-3′. The materials about CMV-Brg1
transgenic mice were presented as supplemental document (Vector Building and
Transgenic Products Report).
Figure 7 Proposed signaling of Brg1-mediated Nrf2/HO-1 pathway activation in
HIR injury. Keap1 dissociation from Nrf2 leads to Nrf2 translocation from cytoplasm to
nucleus during HIR injury. However, with poor efficiency, hepatocyte could not
produce enough antioxidant HO-1, which is the downstream target gene of keap1/
Nrf2 pathway. Upregulation of the chromatin remodeling factor Brg1 could enhance
transcription factor Nrf2 binding to HO-1 DNA sequence and promote HO-1
generation in a high efficiency way. Antioxidant enzyme HO-1 then suppresses the
free radical generated from oxidative burst during hepatocyte H/R injury
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Animals and hepatic warm ischemia–reperfusion model. C57BL/6
mice were obtained from SLAC Laboratory Animal Co. Ltd (Shanghai, China). Mice
were raised and bred in Vaccine Institute Laboratory in the Third Affiliated Hospital
of Sun Yat-Sen University. After a midline laparotomy incision, an atraumatic
vascular clip was placed on the vessels blocking the portal venous and hepatic
arterial blood supply to the median and left lateral lobes of the liver, which resulted
in ~ 70% mouse liver I/R injury.46,47 Some of the CMV-Brg1 mice were received
ZnPP (i.p., 5 mg/kg) 2 h before surgery.48 All animal experiments were approved by
the Animal Care and Used Committee of Sun Yat-Sen University (Guangzhou,
China) and followed the ‘Guide for the Care and Use of Laboratory Animals’ (NIH
Publications no. 8023, revised 1978) guidelines for the treatment of animals.
Cell culture and H/R model. Mice hepatic cells AML12 (ATCC, Manassas,
VA, USA) was maintained following the vendors’ recommendations. H/R was
performed as described in our previous study.49 In brief, cells were placed in Galaxy
48 R hypoxia incubator (Eppendorf Company, Hamburg, Germany) with hypoxia gas
mixture (5% CO2, 94% N2 and 1% O2) at 37 °C. And, following the completion of the
corresponding hypoxia time, cells were then taken out from hypoxia incubator and
placed in 5% CO2 incubator. Cell survival was assessed using the Cell Counting Kit-
8 (CCK-8) and LDH assays.
Liver injury assay. Histology analysis was performed as previously
described.50 Briefly, the liver paraffin sections with hematoxylin and eosin (H&E)
staining were observed under a light microscope by an investigator who was initially
blinded to experimental groups, and five randomly selected fields of each slide were
chose and analyzed, and injury score was graded according to the Suzike’s criteria
in Table 1. Serum AST and ALT levels were determined by a 7180 Biochemical
Analyzer (Hitachi, Japan). 8-Isoprostane (also named 15-F2t-Isoprostane) ELISA
kits (Cayman Chemical Company, Ann Arbor, MI, USA) were used to detect the
levels in the liver tissues.
Plasmids, transfection and reporter assay. Recombinant adenovirus
was generated by homologous recombination and amplified in HEK293 cells. The
Brg1 or HO-1 recombinant adenovirus was, respectively, diluted with DMEM/F12
cell culture medium and added directly to the cells (MOI= 10) at 50% confluence.
After infection for 24 h, the cells were transfected with or without Brg1-siRNA or Nrf2
siRNA for 48 h and then H/R was induced as previously described.50 Plasmids
encoding Nrf2 Neh4 and/or Neh5 mutants (Nrf2 with the Neh4/Neh5 domain
deleted, obtained from GeneCopoeia company, Guangzhou, China) were also used
in the in vitro experiments in AML12 cell line to selectively knockdown the domain of
Nrf2. Silencer negative control scrambled (Scr) siRNA (Ambion Inc., Langhorne, PA,
USA) was used as a control. Tertiary butyl hydroquinone (tBHQ, Sigma-Aldrich) was
dissolved in DMSO and used as a positive Nrf2 activation control. Before use, the
chemicals were dissolved in the culture media at a concentration of 20 μM, keeping
the final carrier concentration at 0.1%. Transient transfections were performed with
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufac-
turer’s protocol.
Luciferase assays were performed with a dual-luciferase reporter kit (Promega
Luciferase Assay System E1501). The pre-processed AML12 cells lysis solution
(20 μl) was collected and added with 100 μl luciferase assay reagent II working liquid.
The luminous value (F) of firefly luciferin enzyme was determinate by GloMax
bioluminescent detector. Then 100 μl Stop & Glo reagent (Promega, Madison, WI,
USA) was added to stop reaction and the luminous value (R) of renilla luciferase was
detected. Relative luciferase activity was counted through F/R. The 3′UTR of the
HO-1 and NQO1 were amplified by PCR using primers and cloned into the PGL3
luciferase reporter vector. HO-1 primers, forward 5′-TGCTAGCCTGGTGCAAGA
TA-3′ and reverse 5′-GCCAACAGGAAGCTGAGAGT-3′; NQO1 primers, forward
5′-GTCCATTC -CAGCTGACAACCA-3′ and reverse 5′-TTGCCCTGAGGCTC
CTAATC-3′. The relative expression of the target genes were calculated using the
2−ΔΔCt method.51
ROS production assay. The ROS production in mice liver tissue was
detected using an OxiSelect intracellular ROS assay kit (Cayman Chemical
Company). Sample homogenate supernatant was incubated with DCFH-DA
(100 μM) at 37 °C for 30 min, and the reaction was terminated by chilling the
reaction mixture in ice. Using a fluorescence spectrophotometer (SpectraMax M5,
Molecular Devices, Sunnyvale, CA, USA), the formation of the oxidized fluorescent
derivative (DCF) was monitored at excitation and emission wavelengths of 480 nm
and 530 nm, respectively. The free radical content was quantified using the
generated DCF standard curve (Supplementary Figure 2A) and the calculated
results were expressed as μmol of DCF/mg protein. ROS in hydrogen peroxide-
treated AML12 cells were also measured as control to ensure the selectivity of DCF
oxidation (Supplementary Figure 2B). In in vitro study, AML12 cells were washed
with ice-cold PBS and incubated with 100 μM DCFH-DA for 30 min at 37 °C. Then,
the medium was discarded and cells were washed with ice-cold PBS in the dark,
and ROS generation was evaluated by the fluorescence intensity measured also by
a fluorescence spectrometry and images were obtained with a florescence
microscope (Olympus, IX51, Tokyo, Japan).
RNA extraction and quantitative real-time PCR analysis. The RNA
of liver tissue and cells were extracted following the manufacturer’s instruction
(Omega, Norcross, GA, USA), and then the purity and integrality were detected as
described in our previous study.52 The levels of mRNA were quantified through RT-
PCR assay using SYBR Green Real-time PCR kit (Takara, Tokyo, Japan) in ABI
PRISM 7500 Sequence Detection System. The primers and Taqman probe set for
real-time reactions were as follows: Nrf2, forward 5′-ACAGTGCTCCTAT GCGTGAA
-3′ reverse 5′-GAGCCTCTAAGCGGCTTGAA-3′; Brg1 forward 5′-AGATGGAGTAG
CCCTTAGCA-3′ and reverse 5′-GAGGTCCCCTCTCTAGACA GTT-3′; HO-1,
forward 5′-TGCTAGCCTGGTGCAAGATA-3′ and reverse 5′-GCCAACAGGAA
GCTGAGAGT-3′; NQO1, forward 5′-GTCCATTCCAGCTGACAACCA-3′ and
reverse 5′-TTGCCCTGAGGCTCCTAATC-3′; GAPDH, forward 5′-GGCCTCCAA
GGAGTAAGAAA-3′ and reverse 5′-GCCCCTCC -TGTTATTATGG-3′. Data were
normalized relative to GAPDH or control group.
ChIP analysis. ChIP assays were implemented using ChIP kit (Millipore,
Germany) according to the instruction with the use of anti-Brg1 (Abcam) antibody.
DNA products from the immunoprecipitation were quantified by qRT-PCR relative to
input. Precipitated genomic DNA was analyzed using Q-PCR method. PCR were
performed against the HO-1 (primers forward 5′-GTGACCCGCGTACTTAAAG-3′
and reverse 5′-TCCACTCACTGGTTGTATGC-3′) or NQO1 (primers forward 5′-CC
TGCTGCA GCTGATATTTC-3′ and reverse 5′-TGATGGATCTCAGTGGAGTCT-3′).
Immunohistochemical assay for HO-1. Paraffin-embedded liver tissue
wax blocks were sectioned at 5 μm. After being dewaxed and rehydrated, the
sections were incubated in 3% hydrogen peroxide/methanol. Heat-induced antigen
retrieval was performed by heating in 10 mM sodium citrate buffer for 10 min.
Sections were incubated in anti-Beclin1 antibody (Cell Signaling Technology) at
1:200 dilution at 4 °C overnight. 3,3′-Diaminobenzidine Substrate Chromogen
System (Dako, Carpinteria, CA, USA) was employed during the detection
procedure. Subsequently, the sections were counterstained using hematoxylin for
10 s. Finally, after being dehydrated in ethanol, cleared in xylene and mounted, the
sections were observed in the light microscope by a pathologist who was initially
blinded to treatment groups, and five random fields of each slide were semi-
quantified and averaged using the software ImageJ 1.48 (National Institutes of
Health, Bethesda, MD, USA) according to its instructions, then come up with the
data of density of target protein positive cell, and the relative density (/sham) of
protein represents the protein expression level of HO-1.
Immunoprecipitation and immunoblotting. Cultured AML12 hepato-
cytes were homogenized in lysis buffer. A total of 500 μg extracts were subjected to
immunoprecipitation with 2 μg Brg1 primary antibody or IgG as negative control in
the presence of 20 ml protein A/G PLUS-Agarose. After extensive PBS washes, the
immunoprecipitates were denatured with sodium dodecyl sulfate loading buffer
and subjected to analysis for Brg1 and Nrf2 expression by western blot as
described below.
Table 1 Suzuki’s histological criteria
Grade Congestion (%) Vacuolization (%) Necrosis (%)
0 None None None
1 Minimal (10) Minimal (10) Minimal (10)
2 Mild (11–30) Mild (11–30) Mild (11–30)
3 Moderate (31–60) Moderate (31–60) Moderate (31–60)
4 Severe (460) Severe (460) Severe (460)
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Protein extraction and western immunoblotting. Whole-cell lysates
(Brg1, NQO1 and HO-1) and nuclear proteins (Nrf2) were performed as described
in our previous study.52 Western blot analyses were performed with anti-Brg1
(1:1000), anti-Nrf2 (1:1000), anti-HO-1 (1:250), anti-NQO1 (1:250), anti-lamin B2
(1:2000) and anti-β-actin (1:2000) antibodies.
Statistical analysis. Data are expressed as mean±S.E.M. Biochemical
assays were performed in triplicate for each specific sample. Therefore, all the data
points are means of numbers themselves resulting from means of triplicate
measurements for these parameters. Significance was evaluated using one-way
ANOVA test (SPSS 13.0, SPSS Inc, Chicago, III) followed by Tukey post hoc
multiple comparisons test for unpaired values. Po0.05 was considered statistically
significant.
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